scholarly article | Q13442814 |
P50 | author | J. Michael Bishop | Q311358 |
P2093 | author name string | M Schwab | |
M B Small | |||
N Hay | |||
P2860 | cites work | Normal rat cell lines deficient in nuclear thymidine kinase | Q42801798 |
Fibroblast lines expressing activated c-myc oncogenes are tumorigenic in nude mice and syngeneic animals | Q42817314 | ||
A nonselective analysis of SV40 transformation of mouse 3T3 cells | Q42833700 | ||
Differential expression of myc family genes during murine development | Q43810784 | ||
Transposition and amplification of oncogene-related sequences in human neuroblastomas | Q45041223 | ||
Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture. | Q53543048 | ||
Construction of a fusion gene that confers resistance against hygromycin B to mammalian cells in culture. | Q54451283 | ||
L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer | Q59081169 | ||
Activated expression of the N-myc gene in human neuroblastomas and related tumors | Q70688632 | ||
Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas | Q93621132 | ||
Human proto-oncogene N-myc encodes nuclear proteins that bind DNA | Q24299897 | ||
Isolation of amplified DNA sequences from IMR-32 human neuroblastoma cells: facilitation by fluorescence-activated flow sorting of metaphase chromosomes | Q24599567 | ||
Nucleotide sequence of the human N-myc gene | Q24632077 | ||
A new technique for the assay of infectivity of human adenovirus 5 DNA | Q27860797 | ||
Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I | Q27860885 | ||
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes | Q28265486 | ||
Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage | Q28272540 | ||
Identification and characterization of the protein encoded by the human N-myc oncogene | Q28287174 | ||
Human N-myc is closely related in organization and nucleotide sequence to c-myc | Q28299447 | ||
Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA | Q29547801 | ||
Transformation of quail embryo fibroblasts by a retrovirus carrying a normal human c-myc gene | Q33879996 | ||
Transformation of mammalian fibroblasts and macrophages in vitro by a murine retrovirus encoding an avian v-myc oncogene | Q33940326 | ||
Amplification units containing human N-myc and c-myc genes | Q35590716 | ||
Human small-cell lung cancers show amplification and expression of the N-myc gene | Q35591132 | ||
A mouse c-myc retrovirus transforms established fibroblast lines in vitro and induces monocyte-macrophage tumors in vivo | Q36864589 | ||
Structure and transforming function of transduced mutant alleles of the chicken c-myc gene | Q36864676 | ||
Tumorigenicity of fibroblast lines expressing the adenovirus E1a, cellular p53, or normal c-myc genes | Q36908146 | ||
Behavior of myc and ras oncogenes in transformation of rat embryo fibroblasts | Q36915093 | ||
Augmented expression of normal c-myc is sufficient for cotransformation of rat embryo cells with a mutant ras gene | Q36952471 | ||
Transcripts from the Cellular Homologs of Retroviral Oncogenes: Distribution Among Chicken Tissues | Q36973279 | ||
N-myc can cooperate with ras to transform normal cells in culture | Q37528796 | ||
Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma | Q37562186 | ||
Homogeneously staining chromosomal regions contain amplified copies of an abundantly expressed cellular oncogene (c-myc) in malignant neuroendocrine cells from a human colon carcinoma | Q37606881 | ||
Avian leukemia viruses: interaction with their target cells in vivo and in vitro | Q37869111 | ||
Translocations among antibody genes in human cancer | Q40161799 | ||
Cellular Oncogenes and Multistep Carcinogenesis | Q40161805 | ||
Rat Insulin Genes: Construction of Plasmids Containing the Coding Sequences | Q40776246 | ||
Expression and amplification of the N-myc gene in primary retinoblastoma | Q41595912 | ||
Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour | Q42799715 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1638-1645 | |
P577 | publication date | 1987-05-01 | |
P1433 | published in | Molecular and Cellular Biology | Q3319478 |
P1476 | title | Neoplastic transformation by the human gene N-myc | |
P478 | volume | 7 |
Q40792892 | A C-terminal domain in FosB, absent in FosB/SF and Fra-1, which is able to interact with the TATA binding protein, is required for altered cell growth. |
Q34323652 | A mouse strain defective in both T cells and NK cells has enhanced sensitivity to tumor induction by plasmid DNA expressing both activated H-Ras and c-Myc |
Q24291788 | A novel c-Myc-responsive gene, JPO1, participates in neoplastic transformation |
Q35034107 | Aberrant expression and function of gap junctions during carcinogenesis |
Q43241094 | Activation of transferrin receptor 1 by c-Myc enhances cellular proliferation and tumorigenesis |
Q36815171 | Altered chromosome 6 in immortal human fibroblasts |
Q24613262 | Alternative processing of RNA transcribed from NMYC |
Q37612854 | Amplification of cellular oncogenes: a predictor of clinical outcome in human cancer |
Q36476838 | Amplification of the MYCN oncogene and deletion of putative tumour suppressor gene in human neuroblastomas |
Q40650986 | Amplified N-myc in human neuroblastoma cells is often arranged as clustered tandem repeats of differently recombined DNA. |
Q35128710 | An in vivo function for the transforming Myc protein: elicitation of the angiogenic phenotype. |
Q59054505 | Chimaeras of Myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells |
Q53462604 | Cyclin A links c-Myc to adhesion-independent cell proliferation. |
Q33846819 | Deregulated expression of human c-jun transforms primary rat embryo cells in cooperation with an activated c-Ha-ras gene and transforms rat-1a cells as a single gene |
Q34428570 | Differential gene expression in SV40-mediated immortalization of human fibroblasts |
Q36708297 | Differential regulation of the N-myc gene in transfected cells and transgenic mice |
Q42814781 | Diverse responses to retinoid in morphological differentiation, tumorigenesis and N-myc expression in human neuroblastoma sublines |
Q42799070 | Effects of SMYD3 overexpression on transformation, serum dependence, and apoptosis sensitivity in NIH3T3 cells. |
Q28576000 | Enhanced RNA polymerase III-dependent transcription is required for oncogenic transformation |
Q37603053 | Escape from p53-mediated tumor surveillance in neuroblastoma: switching off the p14(ARF)-MDM2-p53 axis. |
Q36718316 | Excision of N-myc from chromosome 2 in human neuroblastoma cells containing amplified N-myc sequences |
Q24562145 | Expression, regulation, and chromosomal localization of the Max gene |
Q40961317 | Fra-1 potentiates osteoclastic differentiation in osteoclast-macrophage precursor cell lines |
Q40658745 | Functional analysis of the N-terminal domain of the Myc oncoprotein |
Q34750143 | Genetic parameters of neuroblastomas |
Q33964722 | HMG-I/Y, a new c-Myc target gene and potential oncogene |
Q36230968 | High frequency of myelomonocytic tumors in aging E mu L-myc transgenic mice |
Q41204966 | Human T-cell leukemia virus type I tax masks c-Myc function through a cAMP-dependent pathway |
Q35032893 | Human neuroblastoma cell lines as models for the in vitro study of neoplastic and neuronal cell differentiation |
Q24684304 | Identification of a large Myc-binding protein that contains RCC1-like repeats |
Q41230670 | IgH enhancer deregulated expression of L-myc: abnormal T lymphocyte development and T cell lymphomagenesis |
Q33965061 | Induction of cell cycle progression and acceleration of apoptosis are two separable functions of c-Myc: transrepression correlates with acceleration of apoptosis |
Q24315842 | Interference with the expression of a novel human polycomb protein, hPc2, results in cellular transformation and apoptosis |
Q36791112 | L-myc cooperates with ras to transform primary rat embryo fibroblasts |
Q36004007 | MYC suppresses cancer metastasis by direct transcriptional silencing of αv and β3 integrin subunits |
Q54239289 | MYCN and survivin cooperatively contribute to malignant transformation of fibroblasts. |
Q77304663 | MYCN is the only highly expressed gene from the core amplified domain in human neuroblastomas |
Q37268813 | Mdm2 deficiency suppresses MYCN-Driven neuroblastoma tumorigenesis in vivo |
Q35367195 | Molecular biology in the diagnosis and prognosis of solid and lymphoid tumors |
Q30836209 | Multi-factor data normalization enables the detection of copy number aberrations in amplicon sequencing data |
Q35150661 | Mxi1 and mxi1-0 antagonize N-myc function and independently mediate apoptosis in neuroblastoma |
Q36678903 | Myc-mediated apoptosis is blocked by ectopic expression of Bcl-2 |
Q33667285 | Myc-mediated transformation: the repression connection |
Q37448077 | N-Myc differentially regulates expression of MXI1 isoforms in neuroblastoma |
Q33561040 | N-myc transgene promotes B lymphoid proliferation, elicits lymphomas and reveals cross-regulation with c-myc |
Q28241326 | Negative control of the Myc protein by the stress-responsive kinase Pak2 |
Q37718058 | Neoplastic transformation and tumorigenesis by the human protooncogene MYC. |
Q36476843 | Neuroblastoma--clinical applications of molecular parameters |
Q28082487 | Nonviral oncogenic antigens and the inflammatory signals driving early cancer development as targets for cancer immunoprevention |
Q40059017 | Nuclear colocalization of cellular and viral myc proteins with HSP70 in myc-overexpressing cells |
Q41654945 | Oncogenes in tumor metabolism, tumorigenesis, and apoptosis |
Q24554805 | RING1 interacts with multiple Polycomb-group proteins and displays tumorigenic activity |
Q38322906 | Sequence-specific transcriptional activation by Myc and repression by Max. |
Q39918399 | Stable transfection of CHO cells with the c-myc gene results in increased proliferation rates, reduces serum dependency, and induces anchorage independence |
Q41049587 | Studies of perinuclear and nuclear translocation of the Raf-1 protein in rodent fibroblasts |
Q33686065 | Sustained expression of the human protooncogene MYCN rescues rat embryo cells from senescence |
Q28235132 | Synergistic action of the microRNA-17 polycistron and Myc in aggressive cancer development |
Q34205125 | Synthetic lethal screen identifies NF-κB as a target for combination therapy with topotecan for patients with neuroblastoma |
Q33886720 | Targeted expression of MYCN causes neuroblastoma in transgenic mice |
Q54728996 | The N-myc gene product in primary retinoblastomas. |
Q39445586 | The tmp gene, encoding a membrane protein, is a c-Myc target with a tumorigenic activity |
Q27937937 | The yeast DOA4 gene encodes a deubiquitinating enzyme related to a product of the human tre-2 oncogene |
Q40019974 | Transformation by the Bmi-1 oncoprotein correlates with its subnuclear localization but not its transcriptional suppression activity |
Q36455522 | Transient excess of MYC activity can elicit genomic instability and tumorigenesis |
Q35926080 | Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line |
Q33773293 | Tumors induced in mice by direct inoculation of plasmid DNA expressing both activated H-ras and c-myc |
Q40646003 | Two N-myc polypeptides with distinct amino termini encoded by the second and third exons of the gene |
Q47628529 | Viral Myc oncoproteins in infected fibroblasts down-modulate thrombospondin-1, a possible tumor suppressor gene |
Q33958873 | c-Myc overexpression uncouples DNA replication from mitosis |
Q36238451 | c-Myc transactivation of LDH-A: implications for tumor metabolism and growth |
Q37511853 | myc family oncogenes in the development of normal and neoplastic cells. |
Search more.